The candidate interactors involved in estrogen-, TRIM25- and TP53-associated signaling pathways also suggest cross-talk with anti-apoptotic pathways [122] and additional avenues for further investigation, including potential relevance to NKCC1-based genetic disorders [123]. Here, SLC12A2 is linked to hereditary disease.